Abilifymaintena -

Primarily used for stabilized patients to prevent the return of symptoms.

Approved as a maintenance monotherapy for adults with bipolar I disorder. abilifymaintena

Abilify Maintena is a long-acting injectable antipsychotic used to treat and bipolar I disorder in adults. It contains the active ingredient aripiprazole and is administered by a healthcare professional as a monthly intramuscular injection in the arm or buttock. 🏥 Key Clinical Indications Primarily used for stabilized patients to prevent the

Indicated for the treatment of schizophrenia in adults. abilifymaintena


Copyright (c) 2022 Kiseleva I.V., Ksenafontov A.D.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

abilifymaintena СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 64788 от 02.02.2016.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies